Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone Journal Article


Authors: Arlin, Z. A.; Berman, E.; Jhanwar, S.; Gams, R.; Schoch, I.; Dukart, G.
Article Title: Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone
Abstract: Twenty-four patients with blastic-phase chronic myelogenous leukemia (CML) were treated with mitoxantrone. The patients included 19 whose cells were Philadelphia chromosome (Ph1+) and 5 who were either Ph1- or in whom cytogenetics were not available. Six of the 19 whose cells were Ph1+ responded and one of those who were Ph1- responded. The patients were further characterized into lymphoid or nonlymphoid on the basis of terminal deoxynucleotidyl transferase or morphology. Two of the patients with lymphoid transformation and 3 of those with nonlymphoid transformation responded. In 3 patients post-treatment cytogenetic evaluation revealed the presence of Ph1- metaphases. We conclude that mitoxantrone has modest activity in blCML and that the cytogenetic responses suggest the possibility of greater efficacy in chronic-phase CML. © 1986 Springer-Verlag.
Keywords: adult; cancer chemotherapy; clinical article; aged; middle aged; drug efficacy; chemotherapy; heredity; cytogenetics; chronic myeloid leukemia; histology; drug mechanism; bone marrow biopsy; diagnosis; mitoxantrone; drug therapy; dna nucleotidylexotransferase; therapy; intravenous drug administration; philadelphia 1 chromosome; blast cell; philadelphia chromosome; anthraquinones; leukemia, myelocytic, acute; humans; human; male; female; priority journal; blast transformation; blood and hemopoietic system
Journal Title: Cancer Chemotherapy and Pharmacology
Volume: 17
Issue: 2
ISSN: 0344-5704
Publisher: Springer  
Date Published: 1986-06-01
Start Page: 189
End Page: 190
Language: English
DOI: 10.1007/bf00306753
PUBMED: 3459595
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 18 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Suresh C Jhanwar
    293 Jhanwar
  2. Ellin Berman
    173 Berman